Icosavax, Inc.
ICVX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -92.5% | 382.8% | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | -216.7% | 98.9% | -993.3% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16,185.2% | -831.9% | -1,146.2% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15,199% | -871.6% | -1,187.2% | – |
| EPS Diluted | -2.23 | -3.78 | -6.67 | -0.51 |
| % Growth | 41% | 43.3% | -1,207.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |